News

27.05.26

AusBiotech to unite flagship conferences under Australia’s Biggest Week in Biotech

Following record attendance at AusMedtech 2026, with 550 delegates gathered in Perth, AusBiotech has announced it will align its three flagship conferences together under one major, signature annual event: Australia’s Biggest Week in Biotech.

Read more →

22.05.26

AusBiotech and Tenmile announce strategic partnership

AusBiotech and Tenmile have announced a strategic partnership to support Australia's homegrown life sciences innovation.

Read more →

21.05.26

Life Sciences in Australia: Industry Capability Report 2026

AusBiotech and the Australian Trade and Investment Commission (Austrade) have today jointly released two reports highlighting the scale, deep capability and global connectivity of Australia’s life sciences sector.

Read more →

21.05.26

Life Sciences in Australia: A National Network Driving Innovation 2026

AusBiotech and the Australian Trade and Investment Commission (Austrade) have today jointly released two reports highlighting the scale, deep capability and global connectivity of Australia’s life sciences sector.

Read more →

21.05.26

Austrade and AusBiotech release Industry Capability Reports on Australia's life sciences sector

AusBiotech and the Australian Trade and Investment Commission (Austrade) have today jointly released two reports highlighting the scale, deep capability and global connectivity of Australia’s life sciences sector.

Read more →

20.05.26

The Australian Medical Device Regulatory Scheme: Implementing Recommendations for Reform 2026

This document provides an overview of work being undertaken by AusBiotech and its members to support enhancements to the Australian Medical Device Regulatory Scheme.

Read more →

19.05.26

Australia’s medtech sector convenes in Perth for AusMedtech 2026

AusMedtech 2026 kicks off today at Crown Towers in Perth, Western Australia, bringing together leaders from across the medical technology sector between 19 to 21 May 2026. This year marks the biggest ever delegation with more than 500 attendees.

Read more →

19.05.26

Capital meets innovation: AusBiotech Invest Perth 2026 underway

AusBiotech Invest Perth 2026 opens its doors today at the Crown Towers, bringing together investors, life sciences companies and global partners focused on the next generation of breakthroughs.

Read more →

14.05.26

Australasian Biotechnology Journal Vol 36 No 1

The pace of innovation across Australia’s life sciences sector continues to accelerate, driven not only by breakthrough discoveries, but also by the increasingly powerful convergence of disciplines that were once considered distinct.

Read more →

12.05.26

AusBiotech welcomes some Federal Budget measures but cautions against unintended consequences

AusBiotech says the 2026/27 Federal Budget includes strong signals that the Government has listened and responded to our bold advocacy over the past year but says detail is needed to understand the true impact of the Research and Development Tax Ince

Read more →

17.03.26

AusBiotech welcomes recommendations to build an Ambitious Australia

AusBiotech welcomes today’s release of Ambitious Australia: Strategic Examination of Research and Development Final Report, which calls for urgent action to strengthen Australia’s research, development and innovation (R&DI) system and unlock greater

Read more →

17.03.26

An ambitious Australia will invest in health and medical life sciences

Medicines Australia and AusBiotech today welcome the release of Ambitious Australia: Strategic Examination of R&D Final Report and its plan for action to drive Australia’s future innovation investment through greater focus and a healthy appetite for

Read more →

06.03.26

AusBiotech and Medicines Australia Women in Life Sciences Luncheon and Leadership Summit

More than 650 people, from across Australia’s life sciences ecosystem, will gather in Sydney today for the Women in Life Sciences Leadership Summit and Luncheon, hosted by AusBiotech and Medicines Australia.

Read more →

19.02.26

AusBiotech and Proto Axiom Launch National Partnership to Support Australia’s Next Generation

AusBiotech and Sydney‑based life sciences company creator Proto Axiom have signed a Memorandum of Understanding (MOU) to strengthen national coordination across investor-focused programs connecting researchers, investors, and industry.

Read more →

17.02.26

AusBiotech and Medicines Australia expand Women in Life Sciences partnership

AusBiotech and Medicines Australia will again partner to host the Women in Life Sciences Luncheon in 2026 and, for the first time, have expanded their partnership to deliver the Leadership Summit.

Read more →

03.02.26

AusBiotech and Medicines Australia announce members of new advanced therapies joint advisory group

AusBiotech and Medicines Australia have today announced the members of their newly established Advanced Therapies Advisory Group.

Read more →

02.02.26

AusBiotech reiterates calls for a national whole-of-government approach to life sciences

Australia needs a whole-of-government approach to life sciences to fully capture the sector’s economic value and strategic contribution to national productivity, health security, and improved patient outcomes.

Read more →

13.01.26

AusBiotech selected to join Austrade's Trade Diversification Network

AusBiotech welcomes the Australian Government’s announcement, made by the Minister for Trade and Tourism, Senator the Hon Don Farrell, confirming AusBiotech has been selected to join Austrade’s newly established Trade Diversification Network.

Read more →

24.10.25

AusBiotech welcomes the re-election of Dr Marthe D’Ombrain to its Board of Directors

AusBiotech is pleased to announce the re-election of Dr Marthe D’Ombrain, Head of Global Research Innovation at CSL, to its Board of Directors. She brings more than two decades of leadership and experience.

Read more →

24.10.25

Queensland to host AusBiotech International Conference 2026-27

AusBiotech is delighted to announce the Queensland Government and Tourism and Events Queensland as the Host State Partners for the AusBiotech Invest and AusBiotech International Conference 2026 and 2027 — premier events in the Asia-Pacific region.

Read more →

23.10.25

Global engagement surges as AusBiotech 2025 welcomes delegates from more than 20 countries

Australia’s biotechnology industry is gathering in record numbers at the annual AusBiotech International Conference, held in Melbourne this week.

Read more →

23.10.25

AusBiotech and Taiwan Bio Industry Organization sign MOU to strengthen global life sciences

AusBiotech, Australia’s peak industry body representing more than 3,000 life sciences members, has formalised a new partnership with the Taiwan Bio Industry Organization (Taiwan BIO).

Read more →

23.10.25

AusBiotech and Austrade appoint new national TradeStart role

AusBiotech, Australia’s peak body for the life sciences sector, is delighted to announce the appointment of Tamlyn O’Connor as their new Head of Global Trade and Partnerships. The role is part of an existing partnership.

Read more →

21.10.25

AusBiotech Invest kicks off Australia's biggest week in biotech

Australia’s premier life sciences investment conference, AusBiotech Invest 2025, opens today, welcoming investors, innovators, and global partners to connect with some of Australia’s most investable biotechnology and medical technology companies.

Read more →

15.10.25

Victorian Ministers to speak during Australia’s biggest week in biotech

The Hon Danny Pearson, the Hon Ros Spence, and Ms Michaela Settle will all speak at the flagship events of Australia’s biggest week in biotech — AusBiotech Invest and the AusBiotech International Conference 2025.

Read more →

06.10.25

AusBiotech’s Annual Report captures a defining year for life sciences

AusBiotech has delivered is 2024-25 Annual Report outlining a pivotal year of renewal, growth, and strengthened national advocacy on behalf of Australia’s life science sector.

Read more →

03.10.25

AusBiotech welcomes $13.6M Federal investment to strengthen clinical trials

AusBiotech welcomes the Albanese Government’s announcement of a $13.6 million investment to progress national health and medical research reforms and further strengthen Australia’s clinical trials ecosystem.

Read more →

01.10.25

AusBiotech and Medicines Australia launch new advisory group to accelerate advanced therapies

Expressions of interest are open from current members to join the newly established Advanced Therapies Advisory Group, which will provide input into strategic leadership initiatives supporting Australia’s growing advanced therapies sector.

Read more →

25.09.25

Federal Minister for Industry and Innovation and Minister for Science to address AusBiotech 2025

AusBiotech is delighted to announce that Senator the Hon Tim Ayres MP, Federal Minister for Industry and Innovation and Minister for Science, will address the AusBiotech International Conference.

Read more →

29.08.25

AusBiotech welcomes release of draft National Health and Medical Research Strategy

AusBiotech welcomes the Government’s release of the draft National Health and Medical Research Strategy. Announced by the Hon Mark Butler MP, Minister for Health and Ageing, the 10-year plan will undergo further consultation before final delivery.

Read more →

01.08.25

AusBiotech Annual Report 2025

Australia’s life sciences sector is extraordinary. Every day, the scientists, researchers, clinicians, innovators and entrepreneurs who make up our sector contribute solutions to some of the world’s most complex health challenges.

Read more →

31.07.25

AusBiotech and Medicines Australia celebrate Catalyst outcomes

AusBiotech and Medicines Australia have marked the two-year conclusion of the joint venture Cell & Gene Catalyst by celebrating its outcomes and committing to greater industry collaboration to unify the industry’s efforts and voice.

Read more →

24.06.25

Leading global engagement to strengthen Australia's life sciences sector

AusBiotech, Australia’s peak body representing the innovative life sciences sector, has wrapped a significant week of bilateral and multilateral engagements at the BIO International Convention 2025 (BIO25) in Boston.

Read more →

04.06.25

AusBiotech and Austrade launch partnership for global growth

AusBiotech, Australia’s peak body for the life sciences sector, and the Australian Government's Trade and Investment Commission (Austrade) are partnering to accelerate the global growth and expansion of Australian life science companies.

Read more →

02.06.25

AusBiotech welcomes announcement of Federal Shadow Ministry and encourages bipartisan support

AusBiotech welcomes the announcement of Australia’s federal Shadow Ministry and looks forward to the continued opportunity for engagement with the newly appointed team, as part of its ongoing commitment to supporting a strong, innovative sector.

Read more →

13.05.25

AusBiotech welcomes Albanese Government’s new ministry

AusBiotech welcomes the Albanese Government's announcement of its new cabinet and federal ministry. As the national peak body for Australia’s life sciences sector, AusBiotech congratulates all returning and newly appointed Ministers.

Read more →

07.05.25

AusMedtech 2025: Innovation to Impact — Australia’s leading medtech conference is underway in Sydney

AusBiotech, Australia’s peak body for life sciences, welcomes the start of AusMedtech 2025, which starts today in Sydney, New South Wales (7–8 May 2025).

Read more →

06.05.25

Australia’s premier medtech investment event unites investors and innovators to boost sector growth

AusBiotech's Medtech Invest 2025, Australia’s premier medical technology investment conference, opens today in Sydney, kicking off a landmark week of meaningful connections, collaboration, and growth in devices and diagnostics.

Read more →

06.05.25

AusBiotech and ANDHealth partner to foster sector connection in digital health

AusBiotech has signed a partnership agreement with ANDHealth, the country’s premier provider of commercialisation support and services for the rapidly expanding digital and connected health sector.

Read more →

04.05.25

AusBiotech welcomes the re-election of the Albanese Government and calls for renewed focus

AusBiotech welcomes the re-election of the Albanese Government and the opportunity to continue working in partnership to advance a productive, innovation-driven economy while deepening a whole of government focus on Australia’s life sciences sector.

Read more →

27.03.25

AusBiotech launches Industry Growth Program cohort, welcoming biotech and medtech startups

AusBiotech, Australia’s peak life sciences body, has officially launched its activation program as an Industry Partner Organisation under the Australian Government’s Industry Growth Program.

Read more →

26.03.25

Unlocking Australia’s life sciences: A ‘sleeping giant’ of our economy

While no new significant commitments were made for Australia’s life sciences sector in the 2025-26 Federal Budget, AusBiotech remains steadfast in its advocacy to unlock the full potential of this critical industry for Australia.

Read more →

07.03.25

AusBiotech and Medicines Australia gather industry leaders this International Women’s Day

The organisations are partnering to deliver the annual Women in Life Sciences luncheon, bringing together 600 leaders from across the sector to celebrate the contribution of women in life sciences and call for accelerated action toward gender equity.

Read more →

13.02.25

AusBiotech welcomes national prioritisation of R&D to build a stronger Australia

AusBiotech welcomes the release of the Federal Government’s discussion paper on the Strategic Examination of R&D, underscoring the urgent need for reform to bolster Australia’s innovation ecosystem and global competitiveness.

Read more →

03.02.25

AusBiotech and MTPConnect joint pre-budget submission lays pathway to supercharge the sector

In a pre-budget submission, AusBiotech and MTPConnect have called for new investment in strategic initiatives to boost Australia’s life sciences sector which is central to the nation’s productivity, health security and the health and wellbeing.

Read more →

30.01.25

AusBiotech congratulates members recognised in Australia Day Honours

AusBiotech proudly celebrates the outstanding achievements of members recognised in this year's Australia Day Honours List.

Read more →

01.04.24

National Biotech and Medtech Development Commercialisation Summit 2024

AusBiotech and MTPConnect are delighted to deliver Australia’s first National Biotech and Medtech Development and Commercialisation Summit.

Read more →

01.10.23

Deloitte Economic Impact of the Research and Development Tax Incentive for the Biotech Industry 2023

The Australian biotech industry is a dynamic and rapidly growing sector. Biotech includes the use of living organisms, molecular and synthetic biology to produce healthcare products, therapeutics, diagnostics, and devices.

Read more →

01.08.23

US Investment in Australian Life Sciences Snapshot 2023

The US Investment in Australian Life Sciences Snapshot 2023 (US Investment Snapshot) was commissioned by AusBiotech to quantify the amount of US-originated capital flowing into the sector.

Read more →

01.07.23

National Cell and Gene Manufacturing Blueprint 2023

AusBiotech is pleased to present the National Blueprint for Cell and Gene (C&G) Manufacturing, outlining how, with a united and coordinated plan, Australia can realise the potential of its cell and gene (C&G) manufacturing future.

Read more →

01.01.23

A Practical Guide to ESG for Australian Life Sciences Companies 2023

AusBiotech is pleased to present the inaugural ESG Guide for Australian life sciences companies, with input from individuals and organisations across Australia’s diverse life sciences industry.

Read more →

01.10.22

Australian Biotechnology Sector Snapshot 2022

The Sector Snapshot 2022 (the Snapshot) was commissioned by AusBiotech to provide both an overview of the sector in Australia, in terms of organisation and employment numbers, and to determine how the sector has changed.

Read more →

01.10.22

Research Commercialisation in Australia Companion Report 2022

In 2021 The University of Sydney, Faculty of Medicine and Heath (FMH), The University of Sydney Business School, and AusBiotech commenced a project to develop a global gold standard framework to improve translation and commercialisation.

Read more →

01.10.22

Australia's Regenerative Medicines Investment Database 2021

In Australia, the signs point to increasing interest amongst investors in investing in regenerative medicine (RM) with $394.1m invested in 2020, compared with just $184.7m in 2019, a 113% increase in funding.

Read more →

01.10.22

Accelerating Health and Medical Research Commercialisation in Australia Main Report 2022

This project is a joint initiative between The University of Sydney, Faculty of Medicine and Heath (FMH), The University of Sydney Business School, and AusBiotech.

Read more →

01.09.21

Australia's Regenerative Medicine Global Pipeline Tracker 2021

This Australia’s Regenerative Medicine Clinical Trials Database project was conducted between September 2020 and June 2021 as a key part of the Regenerative Medicine Catalyst Project.

Read more →

01.09.21

Australia's Regenerative Medicine Manufacturing Capacity and Capability 2021

Regenerative Medicine (RM) represents the possibility of revolutionary, lifelong, and curative therapies to meet some of the most pressing unmet medical needs.

Read more →

01.09.21

Regenerative Medicine in Australia: Strategic Roadmap for the Regenerative Medicine Sector 2021

This Catalysing Regenerative Medicine in Australia, Strategic Roadmap was completed between September 2020 and September 2021 as a key part of the Regenerative Medicine Catalyst Project.

Read more →

01.09.21

Australia's Regenerative Medicine Therapies: Case Studies 2021

This Australian Regenerative Medicine Therapies project was conducted between September 2020 and September 2021 as a key part of the Regenerative Medicine Catalyst Project.

Read more →

01.09.21

Australia's Regenerative Medicine Clinical Trials Database (Global Data) 2021

This Australia’s Regenerative Medicine Clinical Trials Database project was conducted between September 2020 and June 2021 as a key part of the Regenerative Medicine Catalyst Project.

Read more →

01.09.21

Australia’s Regenerative Medicine Catalyst Body Funding & Model Structure 2021

The Regenerative Medicine Catalyst Project has brought together seven partners in a consortium to build the foundations for a national regenerative medicines (RM) sector ‘catalyst’ collaboration body.

Read more →

01.09.21

The Regenerative Medicine Value Chain 2021

Regenerative medicine (RM) promises to deliver ground-breaking therapies to Australian patients, with innovative approaches targeting a wide range of conditions including rare genetic diseases, cancers, chronic diseases, and organ damage.

Read more →

01.09.19

Australia's Life Sciences Sector Snapshot 2019

The Sector Snapshot 2019 (the Snapshot) was commissioned by AusBiotech to provide both an overview of the sector in Australia, in terms of organisation and employment numbers, and to determine how the sector has changed since 2017.

Read more →

Where life science leaders thrive

News & Insights

Stay informed with the latest news, insights, reports and publications from across the sector.

Stay informed

We’ll keep you up to date with the latest